Adequate Selection of Oropharynx Carcinoma Treatment in the ElderlyLosada Vila Beatriz*
Hospital University of Fuenlabrada, Calle Camino del Molino, 2, 28942 Fuenlabrada, Madrid, Spain
- *Corresponding Author:
- Losada Vila Beatriz
Hospital University of Fuenlabrada
Calle Camino del Molino, 2
28942 Fuenlabrada, Madrid, Spain
Received Date: April 10, 2017; Accepted Date: April 16, 2017; Published Date: April 26, 2017
Citation: Beatriz LV (2017) Adequate Selection of Oropharynx Carcinoma Treatment in the Elderly. J Cell Sci Apo 1: 105.
Copyright: © 2017 Beatriz LV. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Forty seven percent of patients diagnosed in the US between 1973-2008 were ≥ 65 years old and predicted to be >60% by 2030. However, clinical trials do not usually include patients >70 years, so we do not have experience in this increasing field. We present the case of a 79-year-old patient in whom the treatment decision should be well discussed according to comorbidity, treatment toxicity and survival rates.